The study on the mechanism by which circ_MTHFD2 promotes lung cancer resistance to pemetrexed through microRNA-124XU Fei, MA Leina, FENG Lingxin, WU Yinjie, XU Xiaoyan, YU Zhuang961-967
Study on the effects of CXCL12 on the radiosensitivity of cervical cancerFU Zhichao, CHENG Huihua, LIAO Shaoguang, WANG Fengmei968-972
The effect of CXCR4 inhibitor on radiosensitization of triple negative breast cancerTANG Xinyu, CAO Yuandong, SUN Xinchen973-977
Analysis of the association of H19 gene polymorphisms with susceptibility to prostate cancerCHEN Jianhui, LI Xiaofan, WENG Minggao, CAI Weizhong978-983
Association of TOP2A with the efficacy of adjuvant chemotherapy and epirubicin in gastric cancerLONG Weiguo, LI Xiaoqin, WANG Hongyu, REN Jin, CHEN Deyu, GU Hangang, WANG Deqiang984-989
Expression of ALDH1A1 and ALDH6A1 in hilar cholangiocarcinoma and their clinical significanceXU Lin, YU Wenlong, YU Guanzhen, YU Lei990-995
Expression of Wnt5a and ROR1 in osteosarcoma and their clinical significanceWANG Xingwen, ZHAO Xin, YI Zhigang, PU Yanchuan, MA Bing, WANG Jing, WANG Shuanke996-1000
Tissues and sera levels of NRSN2 in nasopharyngeal carcinoma and their clinical significanceZHANG Weidong, WU Wei, ZHANG Xiujuan1001-1005
Prognostic analysis of thoracic esophageal carcinoma patients with stage pT2-3N0-1M0 after surgeryLIU Yanhu, XUE Dong, LI Juan, TAN Zhenguo1006-1011
Analysis of Mp-MRI based on PI-RADS v2 score combined with PSAD for middle-high grade prostate cancerZHANG Zhen, ZUO Mengzhe, WANG Jianliang1012-1016
